Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia

スポンサーリンク

概要

論文の詳細を見る

著者

関連論文

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade^【○!R】, ICL670) in patients with transfusion-dependent anemias and iron-overload : a Phase I study in Japan
The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes : A Japanese Multicenter Randomized, Controlled Study
Tyrosine Phosphorylation of Proteins in Primary Human Myeloid Leukemic Cells Stimulated by Macrophage Colony-Stimulating Factor: Analysis by Disease Type and Comparison With Normal Human Hematopoietic Cells
Tyrosine phosphorylation of proteins in primary human myeloid leukemia cells stimulated by cytokines: analysis of the frequency of phosphorylation, and partial identification and semi-quantification of signaling molecules
Stable Response after Administration of Stem Cell Factor Combined with Granulocyte Colony-Stimulating Factor in Aplastic Anemia
Chronic neutrophilic leukemia associated with chronic lymphocytic leukemia
Administration of granulocyte colony-stimulating factor during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia
CBFB/MYH11 Fusion Transcripts in A Case of Acute Myelogenous Leukemia (M1) with Partial Deletion of the Long Arm of Chromosome 16
Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia
Combination Therapy with Granulocyte Colony-Stimulating Factor, All-Trans Retinoic Acid, and Low-Dose Cytotoxic Drugs for Acute Myelogenous Leukemia
Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
Clinical efficacy and safety of biapenem for febrile neutropenia in patients with underlying hematopoietic diseases : a multi-institutional study
Romiplostim for the treatment of chronic immune thrombocytopenia in adult Japanese patients : a double-blind, randomized Phase III clinical trial
Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
An open-label extension study evaluating the safety and efficacy of romiplostim for up to 3.5 years in thrombocytopenic Japanese patients with immune thrombocytopenic purpura (ITP)
Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia

もっと見る

スポンサーリンク